Skip to content
SmartFigure
Invesco Mutual Fund

Invesco India Pharma and Healthcare Fund

Invesco Mutual Fund · Direct plan · Growth

  • Equity
  • Sectoral / Thematic Fund
  • Very High Risk
NAV
₹10.58
▲ 0.38% · 13 Nov 2026
Fund size
₹436 Cr
Minimum SIP
₹100

Figures are for the Direct plan. The Regular plan, bought through a distributor, is at ₹10.54 and has returned – over a year.

Returns, and where it stands

Against the average sectoral / thematic fund, and its place among them. Anything longer than a year is a yearly rate.

This fund does not have enough NAV history yet to show returns.

Every period, and the Regular plan →
PeriodDirectRegular
1 month14.4%14.2%

Figures are for the Direct plan, and the rank compares it against the same plan of its peers, best first. Based on NAV history from Sept 2026.

Plan

NAV history

▲ 5.59% in the last 1Y

8.979.7710.610 Sept 202613 Oct 202613 Nov 2026

Hover or tap the chart for the NAV on any date. Past NAVs are adjusted for unit splits.

If you had invested in this fund

Investment type
₹
years

Not enough NAV history for this period.

Fund details

Minimum lumpsum
₹1,000
Minimum top-up
₹1,000
Lock-in
None
Plan started
7 Sept 2026

Managed by Aditya Khemani

Direct plan figures, last checked on 7 Nov 2026. Exit load and the scheme's benchmark are in thescheme document.

How it compares

Invesco India Pharma and Healthcare Fund against other funds in the Sectoral / Thematic Fund category
Fund1Y3Y5YExpenseFund size
Nippon India Taiwan Equity Fund60.64%46.52%–1.06%₹1,147 Cr
HDFC Defence Fund20.34%33.64%–0.89%₹11,493 Cr
HDFC Pharma and Healthcare Fund31.6%31.28%–1.03%₹3,501 Cr
SBI Healthcare Opportunities Fund26.07%25.42%20.65%1.01%₹5,870 Cr
HDFC Transportation and Logistics Fund10.1%24.77%–1.1%₹2,043 Cr
Mirae Asset Healthcare Fund27.89%24.42%17.87%0.62%₹3,494 Cr
Invesco India Pharma and Healthcare Fund––––₹436 Cr

About Invesco India Pharma and Healthcare Fund

Invesco India Pharma and Healthcare Fund is a sectoral / thematic fund managed by Invesco Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.

To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.

The scheme's stated objective, as published by Invesco Mutual Fund.

The NAV (net asset value) is the price of one unit of the fund. It is published by the fund house every business day and changes with the value of the fund's holdings. The Growth option reinvests all gains, so its NAV reflects the fund's total return.

Tax on your gains

Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.

Work out what you would owe with the capital gains tax calculator.

Every plan and option, with scheme codes
PlanOptionNAVScheme code
DirectGrowth₹10.58154547
DirectIDCW₹10.58154546
RegularGrowth₹10.54154545
RegularIDCW₹10.54154544

Frequently asked questions

What is the NAV of Invesco India Pharma and Healthcare Fund today?

The NAV of Invesco India Pharma and Healthcare Fund (Direct plan, Growth) is ₹10.58 and the Regular plan NAV is ₹10.54, as of 13 Nov 2026.

What returns has Invesco India Pharma and Healthcare Fund given?

Over the last year the Direct plan returned –. Past returns do not guarantee future returns.

What is the minimum SIP amount in Invesco India Pharma and Healthcare Fund?

You can start a monthly SIP with ₹100, or invest a lump sum of ₹1,000 or more.

How much has Invesco India Pharma and Healthcare Fund fallen in the past?

Its deepest fall was 11.4% from 23 Sept 2026 to 23 Oct 2026.

Which category does Invesco India Pharma and Healthcare Fund belong to?

It is a Sectoral / Thematic Fund from Invesco Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.

What is the difference between the Direct and Regular plan?

Both invest in the same portfolio. The Direct plan is bought straight from the fund house or a direct platform and has a lower expense ratio because no distributor commission is paid, so its NAV grows slightly faster over time.

How are gains from Invesco India Pharma and Healthcare Fund taxed?

Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.

Source: NAVs published by the fund house through AMFI. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns. This page is for information only and is not a recommendation to buy or sell.